Skip to Main content Skip to Navigation
Journal articles

Unsupervised PrEP in routine practice: a new challenge?

Abstract : Pre-exposure prophylaxis (PrEP) for the prevention of HIV infection with 300 mg daily tenofovir co-formulated with 200 mg emtricitabine is recommended as one prevention option for people who are at substantial risk of acquiring an HIV infection. We report the case of a 28-year-old man who has sex with men and who was referred to our unit for a primary HIV infection with positive p18, p24 and gp160 bands on Western blot analysis but with a low HIV plasma viral load. Although HIV misdiagnosis should always be considered in cases of atypical seroconversion pattern with a low viral burden, unsupervised PrEP should be systematically investigated.
Document type :
Journal articles
Complete list of metadata
Contributor : Administrateur HAL AMU Connect in order to contact the contributor
Submitted on : Wednesday, May 20, 2020 - 10:56:11 AM
Last modification on : Wednesday, November 3, 2021 - 6:45:11 AM




Hélène Laroche, Caroline Lions, Olivia Zaegel-Faucher, Catherine Tamalet, Isabelle Poizot-Martin. Unsupervised PrEP in routine practice: a new challenge?. International Journal of STD and AIDS, SAGE Publications, 2019, 30 (7), pp.715-717. ⟨10.1177/0956462419828872⟩. ⟨hal-02613510⟩



Record views